Therapeutic and market expectancy of recombinant medicines

• Authors: M. Jarecka , P. Borowicz
• Languages of publication: PL

Abstracts

EN

Therapeutic applications and global market of commercialized biopharmaceuticals-recombinant medicines have been presented. The first and second generation of genetically engineered products such as: hormones, cytokines, blood factors, monoclonal antibodies and others approved to date or undergoing clinical investigations in the US and EU have been described. They are used to treat or prevent many diseases, including: diabetes, growth deficiency, anemia, cardio-vascular disorders and, especially, immune-mediated inflammatory disorders and various cancers. The authors have also presented current global biopharmaceutical market, leading biopharmaceuticals, the fastest growing recombinant protein categories and strategic market analysis and forecasts until 2010.

Keywords

EN

BIOPHARMACEUTICS; RECOMBINANT MEDICINE

Discipline

• BIOTECHNOLOGY: BIOTECHNOLOGY

• Publisher: Committee of Biotechnology, Polish Academy of Sciences
• Journal: Biotechnologia
• Year: 2005
• Issue: 4
• Pages: 7-27

Contributors

author

M. Jarecka

author

P. Borowicz

• Document Type: REVIEW
• Publication order reference: Maria Jarecka, Instytut Biotechnologii i Antybiotykow, ul. Staroscinska 5, 02-516 Warszawa, Poland